Unlock instant, AI-driven research and patent intelligence for your innovation.

Nolatrexed dihydrochloride crystal form II as well as preparation method and application of nolatrexed dihydrochloride crystal form II

A technology of lolatrexil hydrochloride and crystal form, which is applied in the field of new crystal forms of compounds, can solve problems such as lolatrexil hydrochloride that have not been seen yet, and achieve the effects of promoting application, improving stability, and ensuring drug safety

Inactive Publication Date: 2017-06-13
BEIJING KONRUNS PHARM CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in the published literature reports, there is no report on the polymorphic form of lolatrexex hydrochloride

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nolatrexed dihydrochloride crystal form II as well as preparation method and application of nolatrexed dihydrochloride crystal form II
  • Nolatrexed dihydrochloride crystal form II as well as preparation method and application of nolatrexed dihydrochloride crystal form II
  • Nolatrexed dihydrochloride crystal form II as well as preparation method and application of nolatrexed dihydrochloride crystal form II

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] The preparation of embodiment 1 lolatrexex hydrochloride crude product

[0041] Add 5g of lolatrex to a mixed solution of 10ml of water and 40ml of methanol, add 1.0ml of concentrated hydrochloric acid, and heat to dissolve completely. Add tetrahydrofuran dropwise until crystals are precipitated, and then stand for crystallization according to the conventional method and then filter to obtain the crude product of lolatrexil hydrochloride, whose powder X-ray diffraction pattern is shown in figure 2 .

Embodiment 2

[0042] Example 2 Nolatrexex hydrochloride crystal form II and its preparation

[0043] Put 5 g of the crude product of lolatrexil hydrochloride (prepared in Example 1) into a 250 ml four-neck flask, add 37.5 ml of methanol, and stir to form a suspension at a stirring speed of 120 rpm; add 0.25 ml of concentrated hydrochloric acid, heat up to 60 ° C, and keep 45min, to dissolve to clear;

[0044] Adjust the stirring speed to 55rpm, and lower the temperature to 32°C at a rate of 1°C / min. When the bottle wall no longer dissolves crystal grains, grow crystals at a constant temperature for 60 minutes, and then continue to slowly cool down to 20°C at a rate of 0.6°C / min. , keep the crystal for 120 minutes;

[0045] After filtration, the wet powder was vacuum-dried at 35°C and -0.092MP for 6.5 hours to obtain the crystal form II of lolatrexex hydrochloride with a purity of 99.4% and a yield of 95%.

[0046] Such as figure 1 As shown, the crystal form II of lolatrexil hydrochloride...

Embodiment 3

[0047] Example 3 Nolatrexex hydrochloride crystal form II and its preparation

[0048] Put 5 g of the crude product of lolatrexil hydrochloride (prepared in Example 1) into a 250 ml four-neck flask, add 30 ml of methanol, stir to form a suspension at a stirring speed of 50 rpm; add 0.15 ml of concentrated hydrochloric acid, heat up to 50 ° C, and keep for 30 min , to dissolve to clear;

[0049] Adjust the stirring speed to 50rpm, and reduce the temperature to 25°C at a rate of 0.5°C / min. When the bottle wall appears undissolved grains; grow crystals at a constant temperature for 60 minutes, and then continue to slowly cool down to 15°C at a rate of 0.4°C / min. , keep the crystal for 90 minutes;

[0050] After filtration, the wet powder was vacuum-dried at 34°C and -0.088MP for 6.5 hours to obtain crystal form II of lolatrexex hydrochloride with a purity of 99.2% and a yield of 92%.

[0051] Such as figure 1 As shown, the crystal form II of lolatrexil hydrochloride is determi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention discloses a nolatrexed dihydrochloride crystal form II. The nolatrexed dihydrochloride crystal form II is determined through a powder X-ray diffraction determination method, and an X-ray powder diffraction pattern represented by diffraction angles of 2theta+ / -0.2 degrees has characteristic diffraction peaks at 6.691 degrees, 12.766 degrees, 16.720 degrees, 17.015 degrees, 17.814 degrees, 21.806 degrees, 22.114 degrees, 23.711 degrees, 24.707 degrees, 25.426 degrees, 26.674 degrees, 29.051 degrees and 29.478 degrees. The crystal form provided by the invention is not reported, has a clear outline and can be perfectly reproducible; the crystal form II has valuable characteristics in the aspects of filtering, drying, stability, method preparation and machinability; the crystal form can be used as an anti-tumor medicine and has wide application prospect.

Description

[0001] This application is a divisional application of application number 201310201443.2 (application date: May 27, 2013, title of invention: a crystal form II of lolatrexex hydrochloride and its preparation method and application). technical field [0002] The invention relates to a new crystal form of a compound, in particular to a crystal form II of nolatrexex hydrochloride and its preparation method and application. Background technique [0003] Lolatrexel hydrochloride was first developed by Agouron Pharmaceuticals in the United States abroad. According to the three-dimensional structural characteristics of the enzyme active center, the company has synthesized a series of thymidylate synthase inhibitors by computer simulation drug molecular technology, and lolatrexate hydrochloride is one of the compounds with the highest inhibitory activity of thymidylate synthase. The company cooperated with RocheSwitzerland to develop lolatrexel hydrochloride as an anti-tumor drug un...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/12A61K31/517A61K9/19A61P35/00
CPCC07D401/12A61K9/0014A61K9/19C07B2200/13
Inventor 王锡娟
Owner BEIJING KONRUNS PHARM CO LTD